2951 - 2975 of 8142 Results
Title
Year
-
OPENTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2019/04/18/613661.full.pdfCitation Count: 4
- A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 Patients2021RESTRICTEDTitle: A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 PatientsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2446End Page: 2448Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28718Citation Count: 7
-
RESTRICTEDTitle: Beyond tics: movement disorders in patients with Tourette syndromeJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 8Start Page: 1177End Page: 1183Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02386-0Citation Count: 16
- Fast and robust supervised machine learning approach for classification and prediction of Parkinson’s disease onset2021RESTRICTEDTitle: Fast and robust supervised machine learning approach for classification and prediction of Parkinson’s disease onsetJournal Name: Computer Methods in Biomechanics and Biomedical Engineering: Imaging & VisualizationPublisher: Informa UK LimitedVol: 9Issue #: 6Start Page: 690End Page: 706Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/21681163.2021.1941262Citation Count: 6
- Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)2021OPENTitle: Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02308-3Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02308-3Citation Count: 30
-
OPENTitle: Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson DiseaseJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001036Best OA location URL: https://nn.neurology.org/content/nnn/8/5/e1036.full.pdfCitation Count: 84
- No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects2021RESTRICTEDTitle: No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjectsJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1187End Page: 1192Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01657-wCitation Count: 1
- Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up2021OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://doi.org/10.1002/brb3.2257Citation Count: 13
- Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 Diabetes2021OPENTitle: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 DiabetesJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1322End Page: 1337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369672Citation Count: 15
- The Discovery of α‐Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a Revolution2021OPENTitle: The Discovery of α‐Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a RevolutionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1189End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13312Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13312Citation Count: 2
- BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease2021OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: http://manuscript.elsevier.com/S1094715922000460/pdf/S1094715922000460.pdfCitation Count: 8
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://air.unimi.it/bitstream/2434/968045/2/Movement%20Disorders%20-%202021%20-%20Laansma%20-%20International%20Multicenter%20Analysis%20of%20Brain%20Structure%20Across%20Clinical%20Stages%20of.pdfCitation Count: 76
- Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life2021OPENTitle: Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of lifeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1668End Page: 1679Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51424Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/169327/2/acn351424.pdfCitation Count: 9
-
OPENTitle: Temporal trajectory of biofluid markers in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-94345-8Best OA location URL: https://www.nature.com/articles/s41598-021-94345-8.pdfCitation Count: 19
- Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models2021OPENTitle: Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1083End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13311Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13311Citation Count: 7
- The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating Factors2021OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 8
- A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson’s Disease2021RESTRICTEDTitle: A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s1Start Page: S27End Page: S34Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202381Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202381?id=journal-of-parkinsons-disease%2Fjpd202381Citation Count: 25
-
OPENTitle: Altered network stability in progressive supranuclear palsyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 107Issue #:Start Page: 109End Page: 117Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.07.007Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.07.007Citation Count: 13
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408600Citation Count: 26
- Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective2021RESTRICTEDTitle: Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder PerspectiveJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s1Start Page: S103End Page: S109Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202428Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202428?id=journal-of-parkinsons-disease%2Fjpd202428Citation Count: 33
-
RESTRICTEDTitle: Domotics, Smart Homes, and Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s1Start Page: S55End Page: S63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202398Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202398?id=journal-of-parkinsons-disease%2Fjpd202398Citation Count: 8
- Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease Cohorts2021OPENTitle: Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1569End Page: 1578Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212657Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212657?id=journal-of-parkinsons-disease%2Fjpd212657Citation Count: 6
- Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography2021OPENTitle: Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational TractographyJournal Name: Journal of Nuclear MedicinePublisher: Society of Nuclear MedicineVol: 63Issue #: 3Start Page: 438End Page: 445Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2967/jnumed.121.261939Best OA location URL: https://jnm.snmjournals.org/content/jnumed/early/2021/07/16/jnumed.121.261939.full.pdfCitation Count: 39
-
OPENTitle: Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1981End Page: 1993Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202487Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202487?id=journal-of-parkinsons-disease%2Fjpd202487Citation Count: 32
-
RESTRICTEDTitle: Video-Based Analyses of Parkinson’s Disease Severity: A Brief ReviewJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s1Start Page: S83End Page: S93Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202402Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202402?id=journal-of-parkinsons-disease%2Fjpd202402Citation Count: 36